Insulin Sensitizers in 2013: New Insights for the Development of Novel Therapeutic Agents to Treat Metabolic Diseases

Expert Opinion on Investigational Drugs - United Kingdom
doi 10.1517/13543784.2013.839659
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare

Related search

Targeting GIRK Channels for the Development of New Therapeutic Agents

Frontiers in Pharmacology
Pharmacology
2011English

Dapagliflozin: A Novel Therapeutic Approach to Treat Diabetes

JMS SKIMS
2011English

Identification of Pharmacological Chaperones as Potential Therapeutic Agents to Treat Phenylketonuria

Journal of Clinical Investigation
Medicine
2008English

A New Drug to Treat Prion Diseases

Lab Animal
Animal ScienceZoologyVeterinary
2019English

Development of a Novel Format of Stable Single Chain Antibodies Against Alkaline Phosphatase as Therapeutic Agents Against Immune Diseases

Journal of Nanomedicine & Biotherapeutic Discovery
2016English

Discovery and Development of Muscarinic Acetylcholine M4 Activators as Promising Therapeutic Agents for CNS Diseases

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2018English

New Insights in the Regulation of Skeletal Muscle PGC-1α by Exercise and Metabolic Diseases

Drug Discovery Today: Disease Models
Drug DiscoveryMolecular Medicine
2013English

Novel Therapeutic Agents for Relapsed Classical Hodgkin Lymphoma

British Journal of Haematology
Hematology
2018English

Development of New Estrogen Receptor-Targeting Therapeutic Agents for Tamoxifen-Resistant Breast Cancer

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy